20
Participants
Start Date
July 31, 2011
Primary Completion Date
November 30, 2012
Study Completion Date
January 31, 2013
Capsules with 160 mg Teavigo (at least 94% EGCG)
Daily intake of 600 mg EGCG for 3 months
Placebo
Daily intake of placebo capsules for 3 months
Franz-Volhard Clinical Research Center at the Experimental and Clinical Research Center, Charité University Medicine Berlin and Max Delbrueck Center for Molecular Medicine, Berlin
Charite University, Berlin, Germany
OTHER